Literature DB >> 73419

Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.

R B Livingston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 73419     DOI: 10.1016/s0305-7372(77)80022-4

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  5 in total

1.  Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinoma.

Authors:  A M Liberati; J G Voelkel; E C Borden; A S Coates; D L Citrin; G T Bryan
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

2.  Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.

Authors:  P Drings; U Abel; H Bülzebruck; P Stiefel; M Kleckow; H G Manke
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Bronchial artery infusion of mitomycin C in carcinoma of the lung.

Authors:  S Ekholm; U Albrechtsson; U Tylén
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

4.  Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer.

Authors:  G P Stathopoulos; D Antoniou; J Dimitroulis; J Stathopoulos; K Marosis; P Michalopoulou
Journal:  Cancer Chemother Pharmacol       Date:  2011-02-08       Impact factor: 3.333

5.  Chemosensitivity testing of human lung cancer cell lines using the MTT assay.

Authors:  J Carmichael; J B Mitchell; W G DeGraff; J Gamson; A F Gazdar; B E Johnson; E Glatstein; J D Minna
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.